NCT01551602View on ClinicalTrials.gov

Clinical Study of AK159 in Healthy Postmenopausal Women

PHASE1CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

October 31, 2012

Conditions
Osteoporosis
Interventions
DRUG

AK159

transdermal administration of teriparatide acetate

DRUG

MN-10-T

subcutaneous administration of teriparatide acetate

DRUG

Placebo

Multiple administration of placebo AK159

Trial Locations (3)

Unknown

Fukuoka

Kumamoto

Tokyo

All Listed Sponsors
lead

Asahi Kasei Pharma Corporation

INDUSTRY

NCT01551602 - Clinical Study of AK159 in Healthy Postmenopausal Women | Biotech Hunter | Biotech Hunter